Mayflower Financial Advisors LLC Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Mayflower Financial Advisors LLC acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 431 shares of the biotechnology company’s stock, valued at approximately $256,000.

Several other hedge funds have also recently bought and sold shares of the business. Public Sector Pension Investment Board raised its position in shares of Axon Enterprise by 79.5% in the second quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock valued at $766,000 after purchasing an additional 1,153 shares during the period. The Manufacturers Life Insurance Company lifted its position in Axon Enterprise by 1.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 43,367 shares of the biotechnology company’s stock worth $12,760,000 after acquiring an additional 535 shares during the last quarter. Creative Planning boosted its holdings in Axon Enterprise by 9.6% during the second quarter. Creative Planning now owns 16,463 shares of the biotechnology company’s stock valued at $4,844,000 after acquiring an additional 1,441 shares during the period. Northwestern Mutual Wealth Management Co. grew its position in shares of Axon Enterprise by 30.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock valued at $236,000 after purchasing an additional 188 shares during the last quarter. Finally, EP Wealth Advisors LLC increased its stake in shares of Axon Enterprise by 18.3% in the second quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company’s stock worth $464,000 after purchasing an additional 244 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Northland Securities increased their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $524.85.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $639.97 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business’s fifty day moving average price is $618.90 and its two-hundred day moving average price is $477.78. Axon Enterprise, Inc. has a fifty-two week low of $247.04 and a fifty-two week high of $698.67. The stock has a market capitalization of $48.80 billion, a price-to-earnings ratio of 165.37, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.